Syngene International Limited

Healthcare · Healthcare Services

NSE: SYNGENE BSE: 539268

₹357.40

Oct. 5, 2026 · NSE · nse_bhavcopy

Peers in Healthcare Services

The largest companies in the same industry by market cap. This company ranks #11 of 62. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Apollo Hospitals Enterprise Limited	114,812	73.1	20.1%	4.2%	—	73	0	27
Max Healthcare Institute Limited	89,246	124.3	13.4%	-19.5%	0.22%	77	0	26
Fortis Healthcare Limited	57,664	255.5	10.5%	-27.5%	0.13%	49	26	6
Global Health Limited	35,830	74.4	13.9%	-2.5%	0.04%	74	0	30
Aster DM Quality Care Limited	35,828	205.8	8.8%	2.8%	0.43%	53	0	26
Narayana Hrudayalaya Ltd.	35,199	61.9	17.8%	-3.7%	0.26%	66	0	29
Dr. Lal Path Labs Ltd.	33,046	38.4	20.1%	-38.0%	0.99%	82	0	88
Krishna Institute of Medical Sciences Limited	29,629	105.1	9.5%	-2.3%	—	47	0	29
Syngene International Limited (this stock)	14,427	62.8	6.5%	-43.7%	0.35%	75	30	11

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹14,307 Cr

EV / EBITDA

20.1x

EV / Sales

4.35x

Market cap / Sales

4.39x

Earnings yield

1.59%

Quarterly Financials

Download CSV

Standalone Consolidated

↓ Negative

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 688 Cr, down 15.7% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	663	-10	-2	₹-0.0500
March 31, 2026	960	197	148	₹3.6800
Dec. 31, 2025	834	30	16	₹0.4100
Sept. 30, 2025	830	84	66	₹1.6500
June 30, 2025	799	84	74	₹1.8400
March 31, 2025	948	229	174	₹4.3400
Dec. 31, 2024	877	170	123	₹3.0700
Sept. 30, 2024	821	124	97	₹2.4100
June 30, 2024	726	99	74	₹1.8400
March 31, 2024	865	210	190	₹4.7300
Dec. 31, 2023	792	125	100	₹2.4900
Sept. 30, 2023	831	131	102	₹2.5300
June 30, 2023	716	92	75	₹1.8800

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	688	982	849	844	816	967	895	838	744	880	821	852	739
Operating revenue	663	960	834	830	799	948	877	821	726	865	792	831	716
Other income	25	22	14	14	17	18	18	16	18	15	29	21	23
Operating expenses	585	676	650	653	631	638	626	613	578	565	592	614	552
Operating profit	78	284	185	178	168	310	251	209	148	299	200	217	163
Operating profit margin	11.8%	29.6%	22.1%	21.4%	21.0%	32.7%	28.6%	25.4%	20.4%	34.6%	25.2%	26.1%	22.8%
Depreciation	96	95	97	100	95	90	92	94	92	96	94	91	89
Interest	4	6	6	7	6	10	7	7	7	8	6	9	6
Exceptional items, gain / (loss)	-14	-7	-66	—	—	—	—	—	32	—	-4	-7	—
Profit before tax	-10	197	30	84	84	229	170	124	99	210	125	131	92
Tax	-8	48	14	18	10	54	47	28	25	21	25	29	16
Net profit	—	148	16	66	74	174	123	97	74	190	100	102	75
EPS	-0.05	3.68	0.41	1.65	1.84	4.34	3.07	2.41	1.84	4.73	2.49	2.53	1.88
Net profit (TTM)	—	305	331	438	468	468	483	460	465	466	466	475	475
EPS (TTM)	5.69	7.58	8.24	10.90	11.66	11.66	12.05	11.47	11.59	11.63	11.61	11.85	11.85

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	3,424	395	305
March 31, 2025	3,373	622	468
March 31, 2024	3,203	557	466
March 31, 2023	3,194	601	473

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	2.3%	—	3,491^†	3,444^†	3,291^†	3,264^†	2,654^†	2,094^†	1,901^†	1,485^†	1,272^†
Operating revenue	2.3%	—	3,424	3,373	3,203	3,194	2,601^†	2,012^†	1,826^†	1,423^†	1,201^†
Other income	—	—	67^†	70^†	88^†	71^†	53^†	82^†	75^†	62^†	71^†
Operating expenses	—	—	2,609^†	2,456^†	2,324^†	2,259^†	1,808^†	1,395^†	1,290^†	959^†	779^†
Operating profit	-4.5%	—	815^†	918^†	879^†	934^†	793^†	617^†	536^†	464^†	422^†
Operating profit margin	—	—	23.8%^†	27.2%^†	27.4%^†	29.3%^†	30.5%^†	30.7%^†	29.3%^†	32.6%^†	35.2%^†
Depreciation	—	—	387^†	367^†	369^†	359^†	310^†	219^†	164^†	131^†	114^†
Interest	—	—	26^†	31^†	30^†	45^†	24^†	35^†	32^†	23^†	18^†
Exceptional items, gain / (loss)	—	—	-73^†	32^†	-11^†	0^†	-31^†	71^†	0^†	0^†	0^†
Profit before tax	-13.0%	—	395	622	557	601	482^†	516^†	414^†	372^†	346^†
Tax	—	—	90^†	154^†	91^†	128^†	88^†	104^†	84^†	67^†	59^†
Net profit	-13.6%	—	305	468	466	473	394^†	412^†	331^†	305^†	287^†
EPS	-13.7%	—	7.58^†	11.66^†	11.63^†	11.81^†	9.78^†	10.36^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	23.8%^†	27.2%^†	27.4%^†	29.3%^†	30.5%^†	30.7%^†	29.3%^†	32.6%^†	35.2%^†
EBIT margin	12.3%^†	19.4%^†	18.3%^†	20.2%^†	19.4%^†	27.4%^†	24.5%^†	27.7%^†	30.3%^†
PBT margin	11.5%	18.4%	17.4%	18.8%	18.5%^†	25.6%^†	22.7%^†	26.1%^†	28.9%^†
Net margin	8.9%	13.9%	14.6%	14.8%	15.1%^†	20.5%^†	18.1%^†	21.4%^†	23.9%^†
Interest coverage	16.20x^†	20.92x^†	19.89x^†	14.29x^†	20.99x^†	15.90x^†	13.82x^†	17.39x^†	20.80x^†
Dividend payout	16.5%^†	10.7%^†	4.3%^†	4.2%^†	0.0%^†	4.8%^†	—	—	—
Earnings retention	83.5%^†	89.3%^†	95.7%^†	95.8%^†	100.0%^†	95.2%^†	—	—	—
Current ratio	1.32x	1.53x	—	—	—	—	—	—	—
Quick ratio	1.23x	1.42x	—	—	—	—	—	—	—
Debt to equity	0.00x	0.02x	—	—	—	—	—	—	—
Return on equity	6.5%	10.1%	—	—	—	—	—	—	—
Return on assets	4.6%	7.3%	—	—	—	—	—	—	—
Return on capital employed	8.2%^†	12.9%^†	—	—	—	—	—	—	—
Asset turnover	0.52x	0.53x	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	831	-784	-178	264	567
March 31, 2025	1,114	-810	-136	369	744
March 31, 2024	913	-384	-536	351	562
March 31, 2023	838	-688	-340	521	317
March 31, 2022	582	-612	-31	475	107

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	6,563	4,704	4,301	0	0	1,876	1,419	120	2,244	137
March 31, 2025	6,407	4,639	4,236	102	0	2,034	1,329	234	1,994	150
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.